10155297

Source:http://linkedlifedata.com/resource/pubmed/id/10155297

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004340, umls-concept:C0007537, umls-concept:C0010181, umls-concept:C0035891
pubmed:issue	1
pubmed:dateCreated	1995-11-14
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9212404
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cefaclor, http://linkedlifedata.com/resource/pubmed/chemical/Roxithromycin
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1170-7690
pubmed:author	pubmed-author:CooperB CBC, pubmed-author:DoveyS MSM, pubmed-author:ScottH MHM, pubmed-author:ScottW GWG, pubmed-author:TilyardM WMW
pubmed:issnType	Print
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	93-4
pubmed:dateRevised	2010-12-1
pubmed:meshHeading	pubmed-meshheading:10155297-Australia, pubmed-meshheading:10155297-Cefaclor, pubmed-meshheading:10155297-Cost-Benefit Analysis, pubmed-meshheading:10155297-Drug Costs, pubmed-meshheading:10155297-Follow-Up Studies, pubmed-meshheading:10155297-Humans, pubmed-meshheading:10155297-Respiratory Tract Infections, pubmed-meshheading:10155297-Roxithromycin, pubmed-meshheading:10155297-Treatment Outcome
pubmed:year	1995
pubmed:articleTitle	Cost effectiveness of roxithromycin versus cefaclor in Australia.
pubmed:publicationType	Letter, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't